Materials and methods for controlling isotope effects during...

Details Materials and methods for controlling isotope effects during... Materials and methods for controlling isotope effects during...

2002-09-27

2008-11-11

Shiao, Rei-tsang (Department: 1626)

Drug, bio-affecting and body treating compositions

Radionuclide or intended radionuclide containing; adjuvant...

C424S001810, C424S001890, C424S009300, C436S173000

Reexamination Certificate

active

07449170

ABSTRACT:
Compositions and methods for controlling or eliminating isotope effects during fractionation of chemically equivalent but isotopically distinct compounds. Isotope coding agents contain heavy isotopes other than deuterium. The invention facilitates intelligent data acquisiton. After sample fractionation, isotope abundance ratios are calculated using mass spectrometry, and analytes of interest are identified in real time.

REFERENCES:
patent: 5393669 (1995-02-01), Brown
patent: 5952653 (1999-09-01), Covey et al.
patent: 6096717 (2000-08-01), Jarvik
patent: 6156527 (2000-12-01), Schmidt et al.
patent: 6391649 (2002-05-01), Chait et al.
patent: 6629040 (2003-09-01), Goodlett et al.
patent: 6670194 (2003-12-01), Aebersold et al.
patent: 6852544 (2005-02-01), Aebersold et al.
patent: 6864099 (2005-03-01), Regnier
patent: 6872575 (2005-03-01), Regnier
patent: 6905879 (2005-06-01), Qui et al.
patent: 7045296 (2006-05-01), Parker et al.
patent: 7052915 (2006-05-01), Aebersold et al.
patent: 7183116 (2007-02-01), Aebersold et al.
patent: 7183118 (2007-02-01), Aebersold et al.
patent: 2002/0037532 (2002-03-01), Regnier et al.
patent: 2002/0049307 (2002-04-01), Aebersold et al.
patent: 2002/0076739 (2002-06-01), Aebersold et al.
patent: 2002/0119490 (2002-08-01), Aebersold et al.
patent: 2002/0168644 (2002-11-01), Aebersold et al.
patent: 2002/0192720 (2002-12-01), Parker et al.
patent: 2003/0054570 (2003-03-01), Qiu et al.
patent: 2003/0087322 (2003-05-01), Aebersold et al.
patent: 2003/0092076 (2003-05-01), Regnier et al.
patent: 2003/0129769 (2003-07-01), Regnier
patent: 2003/0186326 (2003-10-01), Regnier et al.
patent: 2004/0023306 (2004-02-01), Aebersold et al.
patent: 2004/0033625 (2004-02-01), Aebersold et al.
patent: 2004/0038319 (2004-02-01), Aebersold et al.
patent: 2004/0110186 (2004-06-01), Aebersold et al.
patent: 2004/0265810 (2004-12-01), Aebersold et al.
patent: 2005/0095649 (2005-05-01), Aebersold et al.
patent: 2005/0233399 (2005-10-01), Aebersold et al.
patent: 2006/0008851 (2006-01-01), Aebersold et al.
patent: 2006/0141528 (2006-06-01), Aebersold et al.
patent: 2007/0099251 (2007-05-01), Zhang et al.
patent: 2007/0202539 (2007-08-01), Aebersold et al.
patent: 2007/0269895 (2007-11-01), Aebersold et al.
patent: WO 98/32876 (1998-07-01), None
patent: WO 00/09654 (2000-02-01), None
patent: WO 00/09654 (2000-02-01), None
patent: WO 00/11208 (2000-03-01), None
patent: WO 01/86306 (2001-11-01), None
patent: WO 01/86306 (2001-11-01), None
patent: WO 02/46770 (2002-06-01), None
patent: WO 02/46770 (2002-06-01), None
patent: WO 03/027682 (2003-04-01), None
patent: WO 03/027682 (2003-04-01), None
Aebersold et al. “Mass Spectrometry in Proteomis”Chem Rev. 2001;101:269-295.
Amini et al., “The impact of buffers and surfactants from micellar electrokinetic chromatography on matrix-assisted laser desorption ionization (MALDI) mass spectrometry of peptides. Effect of buffer type and concentration on mass determination by MALDI-time-of-flight mass-spectrometry,”Journal of Chromatography A, 894(1-2):345-355 (2000).
Andersen et al., “Functional genomics by mass spectrometry,”FEBS Letters, 480:25-31 (2000).
Anderson et al., “Twenty years of two-dimensional electrophoresis: past, present and future,”Electrophoresis, 1996;17(3):443-453.
Anderson et al., “Back to the future: The human protein index (HPI) and the agenda for post-proteomic biology,”Proteomics, 2001;1:3-12.
Arnott et al., “Selective Detection of Membrane Proteins Without Antibodies,”Molecular&Cellular Proteomics 1.22002;148-156.
Badman et al., “Cylindrical ion trap array with mass selection by variation in trap dimensions,”Anal. Chem. 2000;72:5079-5086.
Bai et al., “High performance hydrophobic interaction chromatography—A new approach to separate intermediates of protein folding,”Chinese Chemical Letters, 8(1):67-70 (1997).
Boersma et al., “19F NMR metabolomics for the elucidation of microbial degradation pathways of fluorophenols,”J. Ind. Microbiol. Biotechnol. 2001;26:22-34.
Chakraborty, Asish, “Comparative Proteomics Based on Global Internal Standard Labeling Technology,” Ph.D. Thesis, Purdue University, (cover date May 2002).
Chen et al., “Site-Specific Mass Tagging with Stable Isotopes in Proteins for Accurate and Efficient Protein Identification,”Anal. Chem. 2000;72:1134-1143.
Clauser et al., “Rapid mass spectrometric peptide sequencing and mass matching for characterization of human melanoma proteins isolated by two-dimensional PAGE,”Proceedings of the National Academy of Sciences USA, 92(11):5072-5076 (1995).
Conrads et al., “Quantitative analysis of bacterial and mammalian proteomes using a combination of cysteine affinity tags and15N-metabolic labeling,”Anal. Chem. 2001;73:2132-2139.
Corthals et al., “Identification of proteins by mass spectrometry,”Proteome Research: Two-Dimensional Gel Electrophoresis and Identification Methods, selected portion available on-line, The Garvan Institute of Medical Research, Biological Mass Spectrometry and Protein Analysis Laboratory [on-line] New York, NY, Springer, 1999 [retrieved on Sep. 12, 2001]. Retrieved from the Internet: <URL: http://www,garvan.unsw.edu.au/public/corthals/book/IPMS.html>, pp. 1-17.
Corthals et al., “Chapter 10: Identification of Proteins by Mass Spectrometry,”Proteome Research: Two-Dimensional Gel Electrophoresis and Identification Methods, Rabilloud, ed., Springer Verlag, Heidelberg, Germany, title page, publication page, and pp. 197-231 (2000).
Corthals et al., “Large-scale proteomics and its future impact on medicine,”Pharmacogenomics J., 2001;1:15-19.
Dass et al., “Manipulation of ion-pairing reagents for reversed-phase high-performance liquid chromatographic separation of phosphorylated opioid peptides from their non-phosphorylated analogues,”J. Chromatogaphy. A, 1994;678:249-257.
Dormady et al., “Eliminating disulfide exchange during glutamyl endopeptidase digestion of native protein,”Journal of Chromatography A, 864:237-245 (1999).
Dunlap et al., “Synthesis and chromatographic characterization of dextran-coated zirconia high-performance liquid chromatographic stationary phases,”Journal of Chromatography A, 746(2):199-210 (1996).
Dwek et al., “Proteome and glycosylation mapping identifies post-translational modifications associated with aggressive breast cancer,”Proteomics2001;1:756-762.
Eng et al., “An Approach to Correlate Tandem Mass Spectral Data of Peptides with Amino Acid Sequences in a Protein Database,”Journal of the American Society for Mass Spectrometry, 5(11):976-989 (1994).
Fiehn, “Combining genomics, metabolome analysis, and biochemical modeling to understand metabolic networks,”Comp. Funct. Genom. 2001;2:155-168.
Geng et al., “Proteomics of Glycoproteins Based on Affinity Selection of Glycopeptides from Tryptic Digests,”Journal of Chromatography B, 752:293-306 (2001).
Goodlett et al., “Protein Identification with a Single Accurate Mass of a Cysteine-Containing Peptide and Constrained Database Searching,”Analytical Chemistry, 72(6):1112-1118 (2000).
Goodlett et al., “Differential stable isotope labeling of peptides for quantitation and de novo sequence derivation,”Rapid Commun. Mass Spectrom. 2001;15:1214-1221.
Griffin et al., “Toward a High-Throughput Approach to Quantitative Proteomics Analysis: Expression-Dependent Protein Identification by Mass Spectrometry,”J. Am. Soc. Mass Spectrom. 2001;12:1238-1246.
Gygi et al., “Quantitative analysis of complex protein mixtures using isotope-coded affinity tags,”Nature Biotechnology, 17(10):994-999 (1999).
Gygi et al., “Measuring gene expression by quantitative proteome analysis,”Current Opinion in Biotechnology, 11(4):396-401 (2000).
Gygi et al., “Mass spectrometry and proteomics,&#

Affiliated with

Also associated with

Rating

Materials and methods for controlling isotope effects during... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Materials and methods for controlling isotope effects during..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Materials and methods for controlling isotope effects during... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4023810